References

1. Lönnerdal B, Iyer S (1995) Lactoferrin: molecular structure and biological function. Annu Rev Nutr 15: 93-110. View
2. Tuccari G, Barresi G (2011) Lactoferrin in human tumours: immunohistochemical investigations during more than 25 years. Biometals 24: 775-784. View
3. Garré C, Bianchi-Scarrá G, Sirito M, Musso M, Ravazzolo R (1992) Lactoferrin binding sites and nuclear localization in K562(S) cells. J Cell Physiol 153: 477-482. View
4. Naidu AS, Miedzobrodzki J, Andersson M, Nilsson LE, Forsgren A, et al. (1990) Bovine lactoferrin binding to six species of coagulase-negative staphylococci isolated from bovine intramammary infections. J Clin Microbiol 28: 2312-2319. View
5. Schaible UE, Collins HL, Priem F, Kaufmann SH (2002) Correction of the iron overload defect in beta-2-microglobulin knockout mice by lactoferrin abolishes their increased susceptibility to tuberculosis. J Exp Med 196: 1507-1513. View
6. Farnaud S, Evans RW (2003) Lactoferrin--a multifunctional protein with antimicrobial properties. Mol Immunol 40: 395-405. View
7. Ikeda M, Sugiyama K, Tanaka T, Tanaka K, Sekihara H, et al. (1998) Lactoferrin markedly inhibits hepatitis C virus infection in cultured human hepatocytes. Biochem Biophys Res Commun 245: 549-553. View
8. Cirioni O, Giacometti A, Barchiesi F, Scalise G (2000) Inhibition of growth of Pneumocystis carinii by lactoferrins alone and in combination with pyrimethamine, clarithromycin and minocycline. J Antimicrob Chemother 46: 577-582. View
9. Kimura M, Nam MS, Ohkouchi Y, Kumura H, Shimazaki Ki, et al. (2000) Antimicrobial peptide of korean native goat lactoferrin and identification of the part essential for this activity. Biochem Biophys Res Commun 268: 333-336. View
10. Omata Y, Satake M, Maeda R, Saito A, Shimazaki K, et al. (2001) Reduction of the infectivity of Toxoplasma gondii and Eimeria stiedai sporozoites by treatment with bovine lactoferricin. J Vet Med Sci 63: 187-190. View
11. Brock JH (2002) The physiology of lactoferrin. Biochem Cell Biol 80: 1-6. View
12. Kanyshkova TG, Buneva VN, Nevinsky GA (2001) Lactoferrin and its biological functions. Biochemistry (Mosc) 66: 1-7. View
13. Legrand D, Pierce A, Elass E, Carpentier M, Mariller C, et al. (2008) Lactoferrin structure and functions. Adv Exp Med Biol 606: 163-194. View
14. Ward PP, Paz E, Conneely OM (2005) Multifunctional roles of lactoferrin: a critical overview. Cell Mol Life Sci 62: 2540-2548. View
15. Cornish J (2004) Lactoferrin promotes bone growth. Biometals 17: 331- 335. View
16. Naot D, Grey A, Reid IR, Cornish J (2005) Lactoferrin--a novel bone growth factor. Clin Med Res 3: 93-101. View
17. Cornish J, Naot D (2010) Lactoferrin as an effector molecule in the skeleton. Biometals 23: 425-430. View
18. Damiens E, El Yazidi I, Mazurier J, Duthille I, Spik G, et al. (1999) Lactoferrin inhibits G1 cyclin-dependent kinases during growth arrest of human breast carcinoma cells. J Cell Biochem 74: 486-498. View
19. Norrby K, Mattsby-Baltzer I, Innocenti M, Tuneberg S (2001) Orally administered bovine lactoferrin systemically inhibits VEGF(165)-mediated angiogenesis in the rat. Int J Cancer 91: 236-240. View
20. Giuffrè G, Barresi V, Skliros C, Barresi G, Tuccari G (2007) Immunoexpression of lactoferrin in human sporadic renal cell carcinomas. Oncol Rep 17: 1021-1026. View
21. Mason DY, Taylor CR (1978) Distribution of transferrin, ferritin, and lactoferrin in human tissues. J Clin Pathol 31: 316-327. View
22. Ieni A, Barresi V, Grosso M, Rosa MA, Tuccari G (2009) Lactoferrin immuno-expression in human normal and neoplastic bone tissue. J Bone Miner Metab 27: 364-371. View
23. Ieni A, Barresi V, Grosso M, Rosa MA, Tuccari G (2009) Immunolocalization of lactoferrin in cartilage-forming neoplasms. J Orthop Sci 14: 732-737. View
24. Antonio I, Valeria B, Maddalena G, Giovanni T (2010) Immunohistochemical evidence of lactoferrin in human embryo-fetal bone and cartilage tissues. Cell Biol Int 34: 845-849. View
25. Ieni A, Barresi V, Grosso M, Speciale G, Rosa MA, et al. (2011) Does lactoferrin behave as an immunohistochemical oncofetal marker in bone and cartilage human neoplasms? Pathol Oncol Res 17: 287-293. View
26. Ieni A, Barresi V, Branca G, Giuffrè G, Rosa MA, et al. (2013) Immunoexpression of lactoferrin in bone metastases and corresponding primary carcinomas. Oncol Lett 5: 1536-1540. View
27. Tuccari G, Villari D, Giuffrè G, Simone A, Squadrito G, et al. (2002) Immunohistochemical evidence of lactoferrin in hepatic biopsies of patients with viral or cryptogenetic chronic liver disease. Histol Histopathol 17: 1077-1083. View
28. Caselitz J, Jaup T, Seifert G (1981) Lactoferrin and lysozyme in carcinomas of the parotid gland. A comparative immunocytochemical study with the occurrence in normal and inflamed tissue. Virchows Arch A Pathol Anat Histol 394: 61-73. View
29. Barresi G, Tuccari G (1984) Lactoferrin in benign hypertrophy and carcinomas of the prostatic gland. Virchows Arch A Pathol Anat Histopathol 403: 59-66. View
30. Charpin C, Lachard A, Pourreau-Schneider N, Jacquemier J, Lavaut MN, et al. (1985) Localization of lactoferrin and nonspecific cross-reacting antigen in human breast carcinomas. An immunohistochemical study using the avidin-biotin-peroxidase complex method. Cancer 55: 2612-2617. View
31. Benaïssa M, Peyrat JP, Hornez L, Mariller C, Mazurier J, et al. (2005) Expression and prognostic value of lactoferrin mRNA isoforms in human breast cancer. Int J Cancer 114: 299-306. View
32. Tuccari G, Barresi G (1985) Immunohistochemical demonstration of lactoferrin in follicular adenomas and thyroid carcinomas. Virchows Arch A Pathol Anat Histopathol 406: 67-74. View
33. Barresi G, Tuccari G (1987) Iron-binding proteins in thyroid tumours. An immunocytochemical study. Pathol Res Pract 182: 344-351. View
34. Cabaret V, Vilain MO, Delobelle-Deroide A, Vanseymortier L (1992) [Immunohistochemical demonstration of ceruloplasmin and lactoferrin in a series of 59 thyroid tumors]. Ann Pathol 12: 347-352. View
35. Tuccari G, Barresi G, Arena F, Inferrera C (1989) Immunocytochemical detection of lactoferrin in human gastric carcinomas and adenomas. Arch Pathol Lab Med 113: 912-915. View
36. Tuccari G, Rizzo A, Crisafulli C, Barresi G (1992) Iron-binding proteins in human colorectal adenomas and carcinomas: an immunocytochemical investigation. Histol Histopathol 7: 543-547. View
37. Tuccari G, Rossiello R, Barresi G (1997) Iron binding proteins in gallbladder carcinomas. An immunocytochemical investigation. Histol Histopathol 12: 671-676. View
38. Tuccari G, Giuffrè G, Crisafulli C, Barresi G (1999) Immunohistochemical detection of lactoferrin in human astrocytomas and multiforme glioblastomas. Eur J Histochem 43: 317-322. View
39. Tuccari G, Giuffrè G, Scarf R, Simone A, Todaro P, et al. (2005) Immunolocalization of lactoferrin in surgically resected pigmented skin lesions. Eur J Histochem 49: 33-38. View
40. Giuffrè G, Arena F, Scarfì R, Simone A, Todaro P, et al. (2006) Lactoferrin immunoexpression in endometrial carcinomas: relationships with sex steroid hormone receptors (ER and PR), proliferation indices (Ki-67 and AgNOR) and survival. Oncol Repo 16: 257-263. View
41. Naot D, Chhana A, Matthews BG, Callon KE, Tong PC, et al. (2011) Molecular mechanisms involved in the mitogenic effect of lactoferrin in osteoblasts. Bone 49: 217-224. View
42. Ieni A, Barresi V, Giuffrè G, Tuccari G (2013) Lactoferrin in Malignant Human Tumours: New Insights from an Immunohistochemical Meta- Analysis. J Analyt Oncol 2: 17-23. View
43. Weinberg ED (1984) Iron withholding: a defense against infection and neoplasia. Physiol Rev 64: 65-102. View
44. Ye XY, Wang HX, Liu F, Ng TB (2000) Ribonuclease, cell-free translationinhibitory and superoxide radical scavenging activities of the iron-binding protein lactoferrin from bovine milk. Int J Biochem Cell Biol 32: 235-241. View
45. Qiu J, Hendrixson DR, Baker EN, Murphy TF, St Geme JW 3rd, et al. (1998) Human milk lactoferrin inactivates two putative colonization factors expressed by Haemophilus influenzae. Proc Natl Acad Sci U S A 95: 12641-12646. View
46. Garré C, Bianchi-Scarrá G, Sirito M, Musso M, Ravazzolo R (1992) Lactoferrin binding sites and nuclear localization in K562(S) cells. J Cell Physiol 153: 477-482. View
47. Penco S, Scarfi S, Giovine M, Damonte G, Millo E, et al. (2001) Identification of an import signal for, and the nuclear localization of, human lactoferrin. Biotechnol Appl Biochem 34: 151-159. View
48. Legrand D, Vigié K, Said EA, Elass E, Masson M, et al. (2004) Surface nucleolin participates in both the binding and endocytosis of lactoferrin in target cells. Eur J Biochem 271: 303-317. View
49. Pepe G, Tenore GC, Mastrocinque R, Stusio P, Campiglia P (2013) Potential anticarcinogenic peptides from bovine milk. J Amino Acids 2013: 939804. View
50. Yin CM, Wong JH, Xia J, Ng TB (2013) Studies on anticancer activities of lactoferrin and lactoferricin. Curr Protein Pept Sci 14: 492-503. View
51. Shi H, Li W (2014) Inhibitory effects of human lactoferrin on U14 cervical carcinoma through upregulation of the immune response. Oncol Lett 7: 820-826. View
52. Ebrahim F, Shankaranarayanan JS, Kanwar JR, Gurudevan S, Krishnan UM, et al. (2014) Identification of unprecedented anticancer properties of high molecular weight biomacromolecular complex containing bovine lactoferrin (HMW-bLf). PLoS One 9: e106568. View
53. Zhang Y, Lima CF, Rodrigues LR (2014) Anticancer effects of lactoferrin: underlying mechanisms and future trends in cancer therapy. Nutr Rev 72: 763-773. View